Detalhe da pesquisa
1.
Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma.
Ann Oncol
; 34(3): 275-288, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36526124
2.
Metronomic chemotherapy (mCHT) in metastatic triple-negative breast cancer (TNBC) patients: results of the VICTOR-6 study.
Breast Cancer Res Treat
; 190(3): 415-424, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546500
3.
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden.
Ann Oncol
; 31(12): 1746-1754, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32866624
4.
Final results of the real-life observational VICTOR-6 study on metronomic chemotherapy in elderly metastatic breast cancer (MBC) patients.
Sci Rep
; 13(1): 12255, 2023 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-37507480
5.
A multicenter phase III prospective randomized trial of high-dose epirubicin in combination with cyclophosphamide (EC) versus docetaxel followed by EC in node-positive breast cancer. GOIM (Gruppo Oncologico Italia Meridionale) 9902 study.
Ann Oncol
; 23(5): 1121-1129, 2012 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21965475
6.
Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.
Ann Oncol
; 23(7): 1838-45, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22100694
7.
A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.
Oncology
; 81(3-4): 230-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22094540
8.
MicroRNA-based signatures impacting clinical course and biology of ovarian cancer: a miRNOmics study.
Biomark Res
; 9(1): 57, 2021 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34256855
9.
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy.
Cancer Invest
; 28(2): 172-80, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19968494
10.
Clinical significance of PTEN and p-Akt co-expression in HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies.
Oncology
; 78(2): 141-9, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20389136
11.
Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
J Hematol Oncol
; 12(1): 111, 2019 10 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665051
12.
Metronomic chemotherapy for advanced breast cancer patients in the real world practice: Final results of the VICTOR-6 study.
Breast
; 48: 7-16, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31470257
13.
[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results]. / CEF (ciclofosfamide, epirubicina, fluorouracile) ad alte dosi come chemioterapia primaria nel trattamento del carcinoma mammario localmente avanzato: risultati a lungo termine.
Clin Ter
; 158(4): 331-41, 2007.
Artigo
em Italiano
| MEDLINE | ID: mdl-17953285
14.
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: New insights beyond clinical trials. The EVA study.
Breast
; 35: 115-121, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28711793
15.
High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
J Exp Clin Cancer Res
; 25(1): 39-44, 2006 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-16761616
16.
Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience.
Breast
; 29: 96-101, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27476084
17.
Targeting immune response with therapeutic vaccines in premalignant lesions and cervical cancer: hope or reality from clinical studies.
Expert Rev Vaccines
; 15(10): 1327-36, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27063030
18.
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.
J Clin Oncol
; 16(1): 86-92, 1998 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-9440727
19.
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial.
J Clin Oncol
; 6(6): 976-82, 1988 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-2897433
20.
Laparoscopic versus robotic radical hysterectomy after neoadjuvant chemotherapy in locally advanced cervical cancer: a case control study.
Eur J Surg Oncol
; 41(1): 142-7, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24063966